The University of Chicago Header Logo

Connection

Michael Thirman to Indazoles

Back to Details
This is a "connection" page, showing publications Michael Thirman has written about Indazoles.
Michael Thirman
Connection Strength
0.143
Indazoles
  1. Entospletinib monotherapy in patients with relapsed or refractory chronic lymphocytic leukemia previously treated with B-cell receptor inhibitors: results of a phase 2 study. Leuk Lymphoma. 2019 08; 60(8):1972-1977.
    View in: PubMed
    Score: 0.143
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.